Tech Company Financing Transactions
Swift Biosciences Funding Round
On 6/13/2017, Swift Biosciences raised $12.2 million in Series D funding from Arboretum Ventures and private investors.
Transaction Overview
Company Name
Announced On
6/13/2017
Transaction Type
Venture Equity
Amount
$12,200,000
Round
Series D
Investors
Arboretum Ventures (Lead Investor) (Dan Kidle)
Proceeds Purpose
The funding will help fuel growth by expanding the company's global commercial channels and enhancing its manufacturing and operational capabilities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
674 S. Wagner Rd. 100
Ann Arbor, MI 48103
USA
Ann Arbor, MI 48103
USA
Phone
Website
Email Address
Overview
Swift Biosciences is developing molecular biology reagents for research and diagnostic applications.Our products help users to detect genes and gene products that other products can't. We also help users to analyze their samples faster, at higher volume, and at a lower price-per-sample.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nathan Wood
Chief Financial Officer
James Militello
Chief Scientific Officer
Vladimir Makarov
VP - Marketing
Camille Cappello
VP - Product Management
Laurie Kurihara
VP - Sales
Haley Fiske
Browse more venture capital transactions:
Prev: 6/13/2017: Vertos Medical venture capital transaction
Next: 6/13/2017: Loyyal venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs